Mkts

Unicycive Therapeutics, Inc.

NASDAQ: UNCY
$3.55-0.09 (-2.47%)
As of Nov 13, 4:00 PM ET

Key statistics

Day range
3.523.69
52-week range
3.338.74
Today
Open3.63
Previous close3.55
Volume—
Valuation
Market cap100.59M
P/E ratio—
EPS (TTM)-1.62
Income & risk
Dividend / yield—
Beta1.85
Avg volume904.7K
Discussion

UNCY News

Stories mentioning UNCY from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.000.000.000.000.000.000.000.00
Operating Expenses
Research & Development1,6072,2362,9641,7502,1715,2883,0454,868
Sales General & Admin
Total Operating Expenses8,4377,2237,3426,9637,9899,2616,2517,401
Operating Income (Loss)(8,437)(7,223)(7,342)(6,963)(7,989)(9,261)(6,251)(7,401)
Interest Income394.00352.00279.00155.00226.00314.00416.00462.00
Interest Expense
Other Expense
Pretax Income
Tax Provision
Net Income (Loss)(12,823)(14,667)(6,011)(6,447)570.00(21,525)(4,096)9,855
Earnings Per Share (Basic)(0.54)(0.92)(0.33)(0.52)0.04(3.21)(0.46)0.80
Earnings Per Share (Diluted)(0.54)(0.92)(0.33)(0.52)(0.50)(3.21)(0.46)(1.50)
Weighted Average Shares Outstanding (Basic)23,90815,88718,06512,30211,6826,6998,8943,791
Weighted Average Shares Outstanding (Diluted)23,90815,88718,06512,30212,3836,6998,8949,405

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About UNCY

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is a stock listed on the Nasdaq Stock Market under the ticker symbol UNCY. It last traded at $3.55 (Nov 13, 2026, 4:00 PM ET), down 2.5% on the day. That gives Unicycive Therapeutics a market capitalisation of $100.6M.

Over the past 52 weeks UNCY has traded between $3.33 and $8.74.

For the quarter ended Mar 31, 2026 it reported a net loss of $12.8M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$12.8M
Dec 31, 2025—-$14.7M
Sep 30, 2025—-$6.0M
Jun 30, 2025—-$6.4M

From Unicycive Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…